Immediate Impact
10 standout
Citing Papers
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024 Standout
Non-small-cell lung cancer
2024 Standout
Works of Corentin Lefebvre being referenced
Fast-progression (FP), hyper-progression (HPD) and early deaths (ED) in advanced non-small cell lung cancer (NSCLC) patients (pts) upon PD-(L)-1 blockade (IO).
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Corentin Lefebvre | 49 | 3 | 47 | 9 | 3 | 53 | |
| Heather Gerrish | 54 | 1 | 57 | 12 | 5 | 59 | |
| Dimitar Kalev | 32 | 33 | 9 | 3 | 47 | ||
| Emmanouil Gratsias | 34 | 5 | 49 | 13 | 2 | 69 | |
| Matthew Lastrapes | 29 | 27 | 12 | 4 | 63 | ||
| Yenarae Lee | 20 | 23 | 5 | 4 | 45 | ||
| Laura Fankhauser | 18 | 3 | 18 | 5 | 2 | 49 | |
| Christina Bechtner | 51 | 1 | 55 | 11 | 3 | 63 | |
| Claire Davoine | 41 | 1 | 48 | 2 | 3 | 53 | |
| Karla Lingard | 14 | 3 | 50 | 4 | 2 | 58 | |
| Bomiao Hu | 22 | 1 | 22 | 4 | 3 | 40 |
All Works
Loading papers...